These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 25755286)
21. Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress. Kruiswijk F; Yuniati L; Magliozzi R; Low TY; Lim R; Bolder R; Mohammed S; Proud CG; Heck AJ; Pagano M; Guardavaccaro D Sci Signal; 2012 Jun; 5(227):ra40. PubMed ID: 22669845 [TBL] [Abstract][Full Text] [Related]
22. Impact of silencing eEF2K expression on the malignant properties of chordoma. Aydemir E; Tüysüz EC; Bayrak ÖF; Tecimel D; Hızlı-Deniz AA; Şahin F Mol Biol Rep; 2023 Apr; 50(4):3011-3022. PubMed ID: 36652154 [TBL] [Abstract][Full Text] [Related]
23. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases. Beretta S; Gritti L; Verpelli C; Sala C Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293 [TBL] [Abstract][Full Text] [Related]
24. Bicuculline regulated protein synthesis is dependent on Homer1 and promotes its interaction with eEF2K through mTORC1-dependent phosphorylation. Gladulich LFH; Xie J; Jensen KB; Kamei M; Paes-de-Carvalho R; Cossenza M; Proud CG J Neurochem; 2021 May; 157(4):1086-1101. PubMed ID: 32892352 [TBL] [Abstract][Full Text] [Related]
25. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Leprivier G; Remke M; Rotblat B; Dubuc A; Mateo AR; Kool M; Agnihotri S; El-Naggar A; Yu B; Somasekharan SP; Faubert B; Bridon G; Tognon CE; Mathers J; Thomas R; Li A; Barokas A; Kwok B; Bowden M; Smith S; Wu X; Korshunov A; Hielscher T; Northcott PA; Galpin JD; Ahern CA; Wang Y; McCabe MG; Collins VP; Jones RG; Pollak M; Delattre O; Gleave ME; Jan E; Pfister SM; Proud CG; Derry WB; Taylor MD; Sorensen PH Cell; 2013 May; 153(5):1064-79. PubMed ID: 23706743 [TBL] [Abstract][Full Text] [Related]
26. Eukaryotic elongation factor-2 (eEF2): its regulation and peptide chain elongation. Kaul G; Pattan G; Rafeequi T Cell Biochem Funct; 2011 Apr; 29(3):227-34. PubMed ID: 21394738 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression. De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820 [TBL] [Abstract][Full Text] [Related]
28. Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases. Liu R; Proud CG Acta Pharmacol Sin; 2016 Mar; 37(3):285-94. PubMed ID: 26806303 [TBL] [Abstract][Full Text] [Related]
29. Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease. Ma T J Neurochem; 2023 Jul; 166(1):47-57. PubMed ID: 34796967 [TBL] [Abstract][Full Text] [Related]
30. A conserved loop in the catalytic domain of eukaryotic elongation factor 2 kinase plays a key role in its substrate specificity. Moore CE; Regufe da Mota S; Mikolajek H; Proud CG Mol Cell Biol; 2014 Jun; 34(12):2294-307. PubMed ID: 24732796 [TBL] [Abstract][Full Text] [Related]
31. Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice. Kasica NP; Zhou X; Yang Q; Wang X; Yang W; Zimmermann HR; Holland CE; Koscielniak E; Wu H; Cox AO; Lee J; Ryazanov AG; Furdui CM; Ma T J Neurochem; 2022 Mar; 160(5):524-539. PubMed ID: 34932218 [TBL] [Abstract][Full Text] [Related]
33. Dynamics of elongation factor 2 kinase regulation in cortical neurons in response to synaptic activity. Kenney JW; Sorokina O; Genheden M; Sorokin A; Armstrong JD; Proud CG J Neurosci; 2015 Feb; 35(7):3034-47. PubMed ID: 25698741 [TBL] [Abstract][Full Text] [Related]
34. Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy. Moore CE; Wang X; Xie J; Pickford J; Barron J; Regufe da Mota S; Versele M; Proud CG Cell Signal; 2016 Apr; 28(4):284-93. PubMed ID: 26795954 [TBL] [Abstract][Full Text] [Related]
35. A decrease in eukaryotic elongation factor 2 phosphorylation is required for local translation of sensorin and long-term facilitation in Aplysia. McCamphill PK; Ferguson L; Sossin WS J Neurochem; 2017 Jul; 142(2):246-259. PubMed ID: 28345161 [TBL] [Abstract][Full Text] [Related]
36. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target. Karakas D; Ozpolat B J Mol Med (Berl); 2020 Jun; 98(6):775-787. PubMed ID: 32377852 [TBL] [Abstract][Full Text] [Related]
37. PQBP1 promotes translational elongation and regulates hippocampal mGluR-LTD by suppressing eEF2 phosphorylation. Shen Y; Zhang ZC; Cheng S; Liu A; Zuo J; Xia S; Liu X; Liu W; Jia Z; Xie W; Han J Mol Cell; 2021 Apr; 81(7):1425-1438.e10. PubMed ID: 33662272 [TBL] [Abstract][Full Text] [Related]
38. Discovery of new substrates of the elongation factor-2 kinase suggests a broader role in the cellular nutrient response. Lazarus MB; Levin RS; Shokat KM Cell Signal; 2017 Jan; 29():78-83. PubMed ID: 27760376 [TBL] [Abstract][Full Text] [Related]
39. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2. Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489 [TBL] [Abstract][Full Text] [Related]
40. Compartment-specific, differential regulation of eukaryotic elongation factor 2 and its kinase within Aplysia sensory neurons. Weatherill DB; McCamphill PK; Pethoukov E; Dunn TW; Fan X; Sossin WS J Neurochem; 2011 Jun; 117(5):841-55. PubMed ID: 21426346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]